Neuraptive Therapeutics, Inc.

Neuraptive Therapeutics, Inc. Neuraptive Therapeutics, Inc. () is a biotechnology company dedicated to developing novel

02/12/2025

Exciting news! Neuraptive has been named a finalist for the Emerging Company of the Year award at the Life Sciences PA 2025 Annual Dinner & Showcase!

This recognition is a testament to the dedication, innovation, and hard work of our incredible team. We are honored to be recognized among such outstanding companies making a difference in the life sciences industry.

A huge thank you to our employees, partners, and supporters who continue to believe in our mission and help us push the boundaries of what’s possible. We look forward to celebrating at the event on March 12, 2025!

Today we celebrate the legacy of a visionary leader who stood for equality, justice, and unity. Dr. King’s dream continu...
01/20/2025

Today we celebrate the legacy of a visionary leader who stood for equality, justice, and unity. Dr. King’s dream continues to inspire us to build a world rooted in compassion, courage, and understanding. Let’s honor his memory by spreading kindness and working together to create a brighter future for all.

As we gather with gratitude this holiday season, the Neuraptive team wishes you a Happy Thanksgiving filled with cherish...
11/27/2024

As we gather with gratitude this holiday season, the Neuraptive team wishes you a Happy Thanksgiving filled with cherished moments and time spent with loved ones.

As we celebrate this Festival of Lights, we extend our heartfelt wishes to our connections and colleagues. May this Diwa...
10/31/2024

As we celebrate this Festival of Lights, we extend our heartfelt wishes to our connections and colleagues. May this Diwali bring you prosperity, success, and new opportunities. Wishing you and your loved ones a joyful and prosperous Diwali!

09/19/2024

Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, today announced that inte

Exciting news for Neuraptive!
09/12/2024

Exciting news for Neuraptive!

Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for acceler

09/11/2024

Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for acceler

Today, we celebrate the dedication, hard work, and achievements of workers across all industries. Remember to take a mom...
09/02/2024

Today, we celebrate the dedication, hard work, and achievements of workers across all industries. Remember to take a moment to rest and recharge and enjoy the Labor Day holiday!

Today, we celebrate the land of the free and the home of the brave. Let's honor the courage and sacrifice of those who f...
07/04/2024

Today, we celebrate the land of the free and the home of the brave. Let's honor the courage and sacrifice of those who fought for our freedom and continue to defend it every day.

Wishing everyone a safe and joyful Fourth of July!

As we celebrate Memorial Day and enjoy time with family and friends, let’s pause to remember and honor the brave men and...
05/25/2024

As we celebrate Memorial Day and enjoy time with family and friends, let’s pause to remember and honor the brave men and women who made the ultimate sacrifice for our country. Their courage, dedication, and love for our nation will never be forgotten and we are forever grateful for their service and sacrifice. Thank you.

03/08/2024

Today, we celebrate the incredible achievements, resilience, and strength of women around the world. Let's acknowledge the progress we've made and commit to fostering a future where equality knows no bounds.

Here's to the women who inspire us every day, breaking barriers, and shaping a better, more inclusive world!

Happy International Women's Day!

We are excited to announce positive 24-week data for NTX-001 in the Phase 2 NEUROFUSE Study, reinforcing previously anno...
02/23/2024

We are excited to announce positive 24-week data for NTX-001 in the Phase 2 NEUROFUSE Study, reinforcing previously announced proof of concept of 12-week data. This is another important milestone in transforming the treatment paradigm for peripheral nerve injuries. Learn more here:

Neuraptive Therapeutics, Inc., a pioneer in nerve repair and regeneration, is proud to announce new 24-week data from the ongoing NEUROFUSE Study for

Address

851 Duportail Road, Suite 200
Chesterbrook, PA
19087

Alerts

Be the first to know and let us send you an email when Neuraptive Therapeutics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Neuraptive Therapeutics, Inc.:

Share